During the first six months of the year SmiLe incubator companies have taken in SEK 85 million, which is 25 percent more than during all of 2018. Taken together, all SmiLe companies – 20 incubator companies and around 50 alumni company – have attracted a total of SEK 595 million during Q1 and Q2. The market value of SmiLe’s 13 listed alumni companies has risen by more than 20 percent during the same period to over SEK 7.2 billion.
During the first half of the year, four of the 20 incubator companies raised funding through new share issues and together received SEK 85 million, with the largest capital injections going to Acrivon and Saga Diagnostics.
The trend has been rising in recent years: all current and former startup companies in SmiLe Incubator have attracted larger and larger amounts from both Swedish and international investors. In 2014 the companies took in a total of SEK 250 million in venture capital – a figure that rose to more than SEK 750 million in 2018. The companies have now attracted SEK 595 million after just the first six months of the year.
“This achievement is a clear acknowledgment of the quality of these companies – in addition to development of world-class products and services, as well as fabulous teams, it is the result of the hard work of these companies at industry and investor meetings, as well as similar exposure opportunities. Life science products require lengthy development before they are ready for the market and can generate value,” says Ebba Fåhraeus, CEO of SmiLe Incubator.
Alumni companies that have made IPO
A1M Pharma AB
B!BB Instruments AB
Clinical Laserthermia Systems AB
Nexam Chemical Holding AB
Phase Holographic Imaging AB
Spago Nanomedical AB